HypeCheck

Updated · AI-assisted evidence analysis

Omni Joints & Mobility Supplement Review 2026: What Does the Evidence Show?

Joint chew leans on ingredient research that is weak or missing for dogs — Overhyped

Share: Post Share

Claims vs Evidence

4 claims assessed. Support depends on the study results, formulation, and population. Matching an ingredient or dose alone does not establish a benefit.

"Supports joint health, movement and mobility in dogs, including the back, knees, elbows and hips" Stretch

Dog studies of glucosamine/chondroitin combinations conflict, and none tested this chew. MSM has no dog evidence in this search. The omega-3 dog trial used a fish-oil diet, and the label gives no omega amount. No joint-specific results (back, knees, elbows, hips) were found for this product.

Source: Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. →

Glucosamine/chondroitin vs carprofen in dogs with osteoarthritis

Randomised, double-blind, positive-controlled multicentre trial; no placebo group; subjective veterinarian scoring · ingredient

Significant improvement in pain, weight-bearing and severity scores by day 70 (P<0.001). Onset was slower than carprofen.

Limitations: Abstract only; no placebo arm; subjective scoring; small sample; only combination tested

Species
dog
Participants / condition
35 dogs with confirmed hip or elbow osteoarthritis
Formulation
Glucosamine hydrochloride plus chondroitin sulfate combination; not this product
Studied amount, not dosing advice
Not reported in abstract
Duration
70 days of treatment; reassessed at day 98 after withdrawal
Funding / conflicts
Not reported in available abstract
Study source ↓
Oral joint supplement vs carprofen in working dogs with hip osteoarthritis

Randomised controlled trial, positive control, double-dummy · ingredient

No overall differences in pain scores between groups. Individual dogs improved on some measures; success in at most 3 of 10 dogs by month 2.

Limitations: Very small; abstract only; no placebo-only arm; blend can't isolate single ingredients

Species
dog
Participants / condition
15 working dogs with hip osteoarthritis (10 supplement, 5 carprofen)
Formulation
Commercial supplement with glucosamine HCl, chondroitin sulphate and hyaluronic acid; not this product
Studied amount, not dosing advice
Not reported in abstract
Duration
40 days supplement; follow-up to 5 months
Funding / conflicts
Not reported in available abstract
Study source ↓
Fish oil omega-3 food and weight bearing in dogs with osteoarthritis

Randomised, double-blinded, controlled trial · ingredient

Peak vertical force rose 5.6% in the test group vs 0.4% in controls; investigators scored lameness and weight bearing better on day 90 vs day 0. Owner questionnaire results are not reported in the abstract.

Limitations: Abstract only; diet trial; short term; omega source differs from the label's unspecified omega fatty acids

Species
dog
Participants / condition
38 client-owned dogs with osteoarthritis at 2 university clinics
Formulation
Food containing fish oil omega-3 fatty acids; not a chew and not this product
Studied amount, not dosing advice
Test food with 3.5% fish oil omega-3 fatty acids
Duration
90 days
Funding / conflicts
Not reported in available abstract
Study source ↓
"Reduces stiffness and helps maintain joint flexibility" No evidence found

The page attributes this to MSM. The search (queries on dog osteoarthritis nutraceutical reviews, the product name, and several other label ingredients) retrieved no dog study of MSM on stiffness or flexibility, and none on this chew. Most records were abstracts and the search was not exhaustive. This is absence of retrieved evidence, not a finding of no benefit.

Source: Omni Joints & Mobility Supplement: manufacturer product page →

"Helps maintain healthy cartilage and joint structure, and supports cartilage repair" Stretch

A 2022 review pooling dog and cat research states that, to the authors' knowledge, no approach has an indication of delaying osteoarthritis progression in pets. Oral hyaluronic acid changed joint-fluid markers in one funded dog trial, which is not cartilage repair. An older dog review rated hyaluronan evidence extremely low.

Source: Systematic review of clinical trials of treatments for osteoarthritis in dogs. →

Oral hyaluronic acid after TTA surgery for cruciate ligament injury

Prospective, randomised, double-blind, placebo-controlled trial · ingredient

Treated group had higher joint-fluid hyaluronic acid (p=0.0016) and lower PON-1 (p=0.011) vs own baseline. No clinical pain or mobility outcome reported.

Limitations: Biomarker outcomes only; comparisons were against baseline, not shown against placebo; post-surgical dogs; only the first part of full text reviewed

Species
dog
Participants / condition
55 dogs after tibial tuberosity advancement surgery for cranial cruciate ligament injury
Formulation
Oral hyaluronic acid; not this product
Studied amount, not dosing advice
Daily amount not reported in available text
Duration
10 weeks
Funding / conflicts
Funded and product supplied by Bioiberica S.A.U.; one author employed by Bioiberica
Study source ↓
Systematic review of clinical trials of osteoarthritis treatments in dogs

Systematic review of 16 trials, FDA evidence scoring · ingredient

Moderate level of comfort for one glucosamine/chondroitin/manganese combination; extremely low level of comfort for hyaluronan.

Limitations: Abstract only; older literature; single trials behind each rating; tests combinations

Species
dog
Participants / condition
Dogs with osteoarthritis across 16 clinical trials
Formulation
Includes one glucosamine/chondroitin/manganese ascorbate combination trial and one hyaluronan trial; not this product
Studied amount, not dosing advice
Not reported in abstract
Duration
Not reported in abstract; search before May 2006
Funding / conflicts
Not reported in available abstract
Study source ↓
"Mild improvement in 2-4 weeks, with full benefits by 3-6 months of daily use" No evidence found

No exact-product trial with a timeline was found in this search, and the search was not exhaustive. The page's 'most dogs' wording isn't backed by a cited study, and the page's review summary is AI-generated customer text, not clinical data.

Source: Omni Joints & Mobility Supplement: manufacturer product page →

Signals

  • The page says 'vet-approved and hypoallergenic', but the reviewed material shows no approval body or allergy testing.
  • 'Fast-acting' conflicts with the page's own timeline of mild change at 2-4 weeks and a three-month minimum.
  • The 4.8-star rating, 200,129+ 'thriving dogs' and 'Backed by Dragons' are customer or investor-TV signals, not clinical evidence.
  • Chondroitin and omega-3 are named in the page text, but the printed ingredient list shows no chondroitin and no named omega-3 source.
  • The full ingredient list and analytical constituents are printed on the page.
  • The feeding guide is published by dog weight band (<15 kg, 15-30 kg, 30 kg+).

Evidence checks

Species and formulation relevance

The dog studies reviewed test other ingredients, blends or fish-oil diets. The 2022 review pools dogs and cats and is used only as pooled context, not as a dog evidence row. No exact-product trial was found in this search. Dog findings on glucosamine/chondroitin conflict, and MSM has no dog results here.

Label transparency

Ingredients and analytical constituents are listed, with a feeding guide by weight. No per-chew amounts were found for glucosamine, MSM, hyaluronic acid or omega fatty acids, so no comparison with studied amounts is possible. Chondroitin appears in the page text but not the ingredient list.

Independent quality testing

No third-party test result or quality seal (such as NASC) for this product appeared in the reviewed material. A B-Corp logo image concerns company impact, not product testing. Independent verification is unknown.

Funding and independence of studies

The hyaluronic acid trial was funded by its ingredient supplier. Funding is not reported in most abstracts. The 2022 pooled review had no proprietary funding but its authors disclose wide industry work.

Sources (8)

  1. 1. Omni Joints & Mobility Supplement: manufacturer product page →

    Manufacturer · Accessed 2026-11-13

  2. 2. Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. →

    Study · Accessed 2026-11-13

  3. 3. Systematic review of clinical trials of treatments for osteoarthritis in dogs. →

    Research review · Accessed 2026-11-13

  4. 4. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. →

    Research review · Accessed 2026-11-13

  5. 5. Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs. →

    Study · Accessed 2026-11-13

  6. 6. Effects of Oral Hyaluronic Acid Administration in Dogs Following Tibial Tuberosity Advancement Surgery for Cranial Cruciate Ligament Injury. →

    Study · Accessed 2026-11-13

  7. 7. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. →

    Research review · Accessed 2026-11-03

  8. 8. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. →

    Study · Accessed 2026-11-13

How this report was produced

AI-assisted evidence analysis. We reviewed published material, not physical products.

Automated source and evidence checks completed on 2026-11-13. These checks are not veterinary review.

Research scope and outstanding checks

Search covered Europe PMC-style queries for dog osteoarthritis nutraceutical reviews, the Omni product name, and L-lysine, omega fatty acids, algae and vitamin C with osteoarthritis. Most records were abstracts only; some full-text excerpts were truncated. Experimental iNOS-inhibitor studies (L-NIL, a lysine analogue) were excluded as not L-lysine. Vitamin E, turmeric, collagen, green-lipped mussel, drug and survey papers were not matched to listed ingredients. Cat and human data were excluded from dog evidence rows; the 2022 review pools dogs and cats and is cited only as pooled context. The search was not exhaustive.

Focused research searches:

  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:nutraceutical* AND TITLE_ABS:osteoarthrit* AND TITLE_ABS:systematic AND TITLE_ABS:review) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (Omni AND Joints AND Mobility) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (Omni AND Joints AND Mobility) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:L-Lysine AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:L-Lysine AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:Omega AND TITLE_ABS:fatty AND TITLE_ABS:acids AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:Omega AND TITLE_ABS:fatty AND TITLE_ABS:acids AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:Algae AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:Algae AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • (TITLE_ABS:Vitamin AND TITLE_ABS:C AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine)
  • (TITLE_ABS:Vitamin AND TITLE_ABS:C AND TITLE_ABS:osteoarthrit*) AND (TITLE_ABS:dog OR TITLE_ABS:dogs OR TITLE_ABS:canine) sort_cited:y
  • Any trial of this Omni chew in dogs found in this search
  • Per-chew amounts of glucosamine, MSM, hyaluronic acid, L-lysine, omega fatty acids and vitamin C
  • Dog evidence for MSM, L-lysine, algae and vitamin C on joint outcomes
  • Third-party testing or quality-seal records for this product
  • Basis for the 'vet-approved' and 'hypoallergenic' statements

More dog supplements reviews

Check another product
Paste a product page to request an automated evidence review.